GlaxoSmithKline (GSK) Consumer Healthcare is voluntarily recalling all alli® weight loss products from the United States and Puerto Rico retailers as the company believes that some packages of the product were tampered with and may contain product that is not authentic alli®. GSK is conducting an investigation and is working with the knowledge of the FDA on this retailer-level recall.

GSK received inquiries from consumers in seven states about bottles of alli® that contained tablets and capsules that were not alli®  A range of tablets and capsules of various shapes and colors were reported to be found inside bottles. Additionally, some bottles inside the outer carton were missing labels and had tamper-evident seals that were not authentic.These tampered products were purchased in retail stores. The company had initially limited the recall to those seven states (Alabama, Florida, Louisiana, Mississippi, New York, North Carolina, and Texas) and has now extended the recall to include.alli® weight loss products from the United States and Puerto Rico retailers

“Safety is our first priority and we are asking retailers and pharmacies to remove all alli from their shelves immediately,” said Colin Mackenzie, President Consumer Healthcare North America. The company posted a Consumer Alert on its website for the product, www.myalli.com, and issued information and photographs to help consumers determine if their alli is authentic.

alli® is a turquoise blue capsule with a dark blue band imprinted with the text “60 Orlistat”. It is packaged in a labeled bottle that has an inner foil seal imprinted with the words: “Sealed for Your Protection.” Consumers should confirm any alli® in their possession matches this.

Source: GlaxoSmithKline